Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HALO · as of Jun 8, 2026
Key Statistics
Explore Halozyme Therapeutics, Inc. Data
halo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 27 · Buy rate: 63.0%
The HALO analyst consensus is Buy, based on ratings from 27 Wall Street analysts over the past 3 months. The average 12-month price target is $88.25, representing +23.37% upside from the current price of $71.53.
Competitors & Peers
halo competitorsHALO
ABVX
ATR
CAI
CORT
CYTKStock Performance
Full HistoryAbout Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the…
what is halozyme therapeutics, inc. · halo stock overview · halozyme therapeutics, inc. company profile · who is halozyme therapeutics, inc. ceo · halo NASDAQ · halozyme therapeutics, inc. headquarters · halozyme therapeutics, inc. business segments
About Stock Overview & Key Data
Halozyme Therapeutics, Inc. (HALO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 16, 2004. As of the latest trading session, HALO stock price is $71.53, with a market capitalization of $8.5B. The stock has returned +31.54% over the past 12 months and +6.29% year-to-date.
According to 27 Wall Street analysts, the consensus rating for Halozyme Therapeutics, Inc. stock is Buy, with an average 12-month price target of $88.25. In fiscal year 2025, Halozyme Therapeutics, Inc. reported revenue of $1.4B and net income of $316.9M. For detailed data — including Halozyme Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Halozyme Therapeutics, Inc. (HALO) stock price is $71.53. The stock is traded on NASDAQ under the ticker symbol HALO. The 52-week range is $51.06 – $82.22.